Atlas Venture Fund XI, L.P.

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 40% 68% 82%
Transactions
11 18% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -95%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Atlas Venture Fund XI, L.P.'s trades of Dyne Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07
PrS Proposed sale
87,496
240.76
US$2,979,085 		87,496 240.76 US$2,979,085
2026-07-07 2026-07-07
PrS Proposed sale
7,004
174.25
US$3,299,646 		7,004 174.25 US$3,299,646
2026-07-06 2026-07-06
PrS Proposed sale
68,334
462.83
US$2,003,165 		68,334 462.83 US$2,003,165
2026-07-06 2026-07-06
US Korro Bio Inc (KRRO)
PrS Proposed sale
817
14.00
US$11,438 		817 14.00 US$11,438
2026-07-02 2026-07-02
US Korro Bio Inc (KRRO)
PrS Proposed sale
85,955
13.65
US$1,173,286 		85,955 13.65 US$1,173,286
2026-06-29 2026-06-29
PrS Proposed sale
102,969
20.94
US$2,156,171 		102,969 20.94 US$2,156,171
2026-06-26 2026-06-26
PrS Proposed sale
162,954
20.61
US$3,358,482 		162,954 20.61 US$3,358,482
2026-06-25 2026-06-25
PrS Proposed sale
12,699
20.33
US$258,171 		12,699 20.33 US$258,171
2026-06-24 2026-06-24
US Korro Bio Inc (KRRO)
PrS Proposed sale
41,345
13.71
US$566,840 		41,345 13.71 US$566,840
2026-06-24 2026-06-24
PrS Proposed sale
50,530
20.26
US$1,023,738 		50,530 20.26 US$1,023,738
2026-06-23 2026-06-23
US Korro Bio Inc (KRRO)
PrS Proposed sale
101,579
13.90
US$1,411,948 		101,579 13.90 US$1,411,948
2026-06-23 2026-06-22
PrS Proposed sale
77,855
20.87
US$1,624,834 		77,855 20.87 US$1,624,834
2026-06-22 2026-06-22
US Korro Bio Inc (KRRO)
PrS Proposed sale
21,339
12.99
US$277,194 		21,339 12.99 US$277,194
2026-05-06 2026-05-06
PrS Proposed sale
43,621
17.47
US$762,059 		43,621 17.47 US$762,059
2026-05-05 2026-05-05
PrS Proposed sale
6,081
17.71
US$107,695 		6,081 17.71 US$107,695
2026-05-04 2026-05-04
PrS Proposed sale
6,241
17.39
US$108,531 		6,241 17.39 US$108,531
2026-04-28 2026-04-28
PrS Proposed sale
119,167
18.04
US$2,149,773 		119,167 18.04 US$2,149,773
2026-04-27 2026-04-27
PrS Proposed sale
90,943
18.26
US$1,660,619 		90,943 18.26 US$1,660,619
2026-04-24 2026-04-24
PrS Proposed sale
72,310
18.90
US$1,366,659 		72,310 18.90 US$1,366,659
2026-04-23 2026-04-23
PrS Proposed sale
38,322
19.67
US$753,794 		38,322 19.67 US$753,794
2026-04-22 2026-04-22
PrS Proposed sale
150,942
19.21
US$2,899,596 		150,942 19.21 US$2,899,596
2026-04-21 2026-04-21
PrS Proposed sale
143,749
20.02
US$2,877,855 		143,749 20.02 US$2,877,855
2026-04-20 2026-04-20
PrS Proposed sale
142,571
20.41
US$2,909,874 		142,571 20.41 US$2,909,874
2025-10-21 2025-10-21
PrS Proposed sale
73,460
32.20
US$2,365,412 		73,460 32.20 US$2,365,412
2025-10-20 2025-10-20
PrS Proposed sale
46,273
31.93
US$1,477,497 		46,273 31.93 US$1,477,497
2025-10-17 2025-10-17
PrS Proposed sale
50,520
32.72
US$1,653,014 		50,520 32.72 US$1,653,014
2025-10-16 2025-10-16
PrS Proposed sale
139,897
30.91
US$4,324,216 		139,897 30.91 US$4,324,216
2025-10-14 2025-10-14
PrS Proposed sale
501
29.31
US$14,684 		501 29.31 US$14,684
2025-10-14 2025-10-13
PrS Proposed sale
48,130
29.42
US$1,415,985 		48,130 29.42 US$1,415,985
2025-10-10 2025-10-10
PrS Proposed sale
16,727
28.35
US$474,210 		16,727 28.35 US$474,210
2025-10-06 2025-10-06
PrS Proposed sale
9,753
30.01
US$292,688 		9,753 30.01 US$292,688
2025-10-03 2025-10-03
PrS Proposed sale
31,198
29.30
US$914,101 		31,198 29.30 US$914,101
2025-10-01 2025-10-01
PrS Proposed sale
165
29.41
US$4,853 		165 29.41 US$4,853
2025-09-29 2025-09-29
PrS Proposed sale
54,637
28.94
US$1,581,195 		54,637 28.94 US$1,581,195
2025-02-10 2025-02-10
B Purchase
60,000 +8.0%
18.00
US$1,080,000 		60,000 +8.0% 18.00 US$1,080,000
2024-02-28 2024-02-28
PlS Planned sale
210 -0.0%
25.25
US$5,302 		210 -0.0% 25.25 US$5,302
2024-02-28 2024-02-28
PlS Planned sale
13,109 -1.5%
24.83
US$325,496 		13,109 -1.5% 24.83 US$325,496
2024-02-28 2024-02-28
PlS Planned sale
360 -0.0%
25.25
US$9,090 		360 -0.0% 25.25 US$9,090
2024-02-28 2024-02-28
PlS Planned sale
22,567 -1.5%
24.83
US$560,339 		22,567 -1.5% 24.83 US$560,339
2024-02-28 2024-02-28
PlS Planned sale
2,430 -0.0%
25.25
US$61,358 		2,430 -0.0% 25.25 US$61,358
2024-02-28 2024-02-28
PlS Planned sale
152,244 -2.6%
24.83
US$3,780,219 		152,244 -2.6% 24.83 US$3,780,219
2024-02-28 2024-02-27
PlS Planned sale
2,216 -0.3%
24.68
US$54,691 		2,216 -0.3% 24.68 US$54,691
2024-02-28 2024-02-27
PlS Planned sale
23,505 -2.6%
24.38
US$573,052 		23,505 -2.6% 24.38 US$573,052
2024-02-28 2024-02-27
PlS Planned sale
3,821 -0.3%
24.68
US$94,302 		3,821 -0.3% 24.68 US$94,302
2024-02-28 2024-02-27
PlS Planned sale
40,455 -2.6%
24.38
US$986,293 		40,455 -2.6% 24.38 US$986,293